AFX Carl Zeiss Meditec AG

DGAP-News: Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events

DGAP-News: Carl Zeiss Meditec AG / Key word(s): AGM/EGM
Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events

17.03.2020 / 10:38
The issuer is solely responsible for the content of this announcement.


Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events
 
 

JENA, 17 March 2020

On the basis of the decree of the President of the State Administration Office of Thuringia (Landesverwaltungsamt Thüringen) of 14 March 2020, according to which "events and meetings of people with 50 or more persons must be prohibited from now until further notice", the Management Board of Carl Zeiss Meditec AG has decided to postpone the Annual General Meeting, which was scheduled for Tuesday, 24 March 2020 (published in the Federal Gazette (Bundesanzeiger) of 11 February 2020); it will therefore not take place. A new date will be announced in time.

 

Contact for investors and press

Sebastian Frericks
Director Investor Relations, Carl Zeiss Meditec AG
Tel. 03641 220-116
E-Mail:



17.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail:
Internet: /meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 999125

 
End of News DGAP News Service

999125  17.03.2020 

fncls.ssp?fn=show_t_gif&application_id=999125&application_name=news&site_id=research_pool
EN
17/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Carl Zeiss Meditec AG

Thomas J. Schiessle
  • Thomas J. Schiessle

25er Guidance erreichbar, aber US-Zölle und FX-Effekte belasten

Q3/25 wurde durch negative FX-Effekte und US-Zölle gedämpft (YoY in CC: Q3-Umsatz/ Q3-EBITA: +3,5 %/ +9 %), die Vollkonsolidierung DORC unterstützte das Volumenwachstum - die adj. Marge stieg YoY um 50 BP auf 7,7 %. Die Orderdynamik, und damit die Produktionsreichweite, nahm jüngst zu. Das 9M/25-adj. EPS erreichte € 1,24 (9M/24: € 1,35).

Thomas J. Schiessle
  • Thomas J. Schiessle

25 guidance achievable, but US tariffs and FX effects are a burden

Q3/25 was dampened by negative FX effects and US tariffs (YoY in CC: Q3 revenue/Q3 EBITA: +3.5%/+9%), the full consolidation of DORC supported volume growth - the adjusted margin increased by 50 BP YoY to 7.7%. Order dynamics, and thus production capacity, have recently increased. The 9M/25 adjusted EPS reached €1.24 (9M/24: €1.35).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch